Sharekhan's research report on Emami
Emami’s Q3FY2023 numbers were muted, affected by weak rural demand and a delayed winter. Revenue stood flat while operating profit decreased by 14% y-o-y during the quarter. The management is expecting a 10-12% revenue growth in FY2024 with expected recovery in the rural demand and improved growth in some key categories such as healthcare products and pain management. With raw material prices correcting from its highs, OPM is expected to improve substantially in Q4. It expects OPM to stand at 27% for FY2023 and improve consistently in the coming years as the mix will improve.
Outlook
The stock trades at 24.4x/20.8x/17.2x its FY2023E/FY2024E/FY2025E earnings. We maintain Buy with a revised PT of Rs. 500.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.